Related Experiment Video
Updated: Feb 27, 2026
Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
A novel and rapid method to quantify Treg mediated suppression of CD4 T cells
Anna E Long1, Megan Tatum1, Carmen Mikacenic2
1Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
Insights
A new assay measures regulatory T cell suppression using surface markers, applicable to frozen and limited cell samples. This rapid method aids in studying T cell dysfunction in autoimmune diseases and infections.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Regulatory T cells (Tregs) are crucial for immune homeostasis and preventing autoimmunity.
- Current Treg suppression assays require fresh cells and large quantities, limiting their clinical applicability.
Purpose of the Study:
- To develop a novel, rapid, and versatile in vitro assay for measuring Treg-mediated suppression.
- To establish a surrogate marker-based assay that overcomes limitations of traditional proliferation assays.
Main Methods:
- Utilized effector T cell surface expression of CD25 and CD134 as a surrogate marker for Treg suppression.
- Validated the assay with frozen samples, limited cell numbers, and various Treg sources and stimulation conditions.
Main Results:
- The novel assay accurately measures Treg suppression using CD25 and CD134 expression.
- The assay is effective with cryopreserved samples and low cell numbers, reducing assay time to two days.
Conclusions:
- A validated, rapid, surface marker-based assay for Treg suppression has been developed.
- This assay facilitates the investigation of T cell regulation in autoimmune diseases and infections, even with limited or cryopreserved samples.
Abstract:
Measuring regulatory T cell suppression provides important insight into T cell dysfunction in autoimmune disease. However, to date, suppression assays are limited by the requirement for freshly isolated cells, and significant cell numbers. Here, we present a novel and rapid in vitro assay using effector T cell surface expression of both CD25 and CD134 as a surrogate marker of regulatory T cell-mediated suppression. This surface marker-based suppression assay works for frozen samples and for samples with limited cell numbers. It is also shorter taking two days to complete compared to the four days required for proliferation-based assays. Furthermore, this assay works with both in vitro expanded and natural Tregs, as well as anti-CD3/anti-CD28 bead-based and APC stimulation conditions. In conclusion, we have developed and validated a new suppression assay for cryopreserved samples with limited cell numbers that may be helpful to investigate T cell regulation in the context of infection or autoimmune diseases.
